Morphine withdrawal alters anterior pituitary hormone secretion, brain endopeptidase activity and brain monoamine metabolism in the rat

Pharmacology and Toxicology

Volumn 78, Issue 3, 1996, Pages 129-135

  Idanpaan Heikkila, Juhana J ^a   Rauhala, Pekka ^a   Tuominen, Raimo K ^a   Tuomainen, Päivi ^a   Zolotov, Nikolai ^a   Männistö, Pekka T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYPOPHYSIS HORMONE; MORPHINE; PROLACTIN; PROTEINASE; THYROTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; CONTROLLED STUDY; DRUG WITHDRAWAL; HORMONE RELEASE; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONOAMINE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

EID: 0029929395     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00193.x     Document Type: Article

References (46)

1. Ahtee, L., L. M. J. Attila, K. R. Carlson & H. Haikala: Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state. J. Pharmacol. Exp. Therap. 1989, 249, 303-310.
2. 1-adrenergic facilitatory control of the cold-induced TRH release in the rat, obtained by push-pull cannulation of the median eminence. Neurosci. Lett. 1989, 100, 169-174.
3. Armario, A. & T. Jolín: Influence of intensity and duration of exposure to various stressors on serum TSH and GH levels in adult male rats. Life Sci. 1989, 44, 215-221.
4. Armario, A., O. Martí, A. Gavaldà, M. Giralt & J. Jolín: Effects of chronic immobilization stress on GH and TSH secretion in the rat: response to hypothalamic regulatory factors. Psychoneuroendocrinology 1993, 18, 405-413.
5. Baker, H. J., J. R. Lindsey & S. H. Weisbroth: Housing to control research variables. In: The laboratory rat. Ed.: H. J. Baker, J. R. Lindsey & S. H. Weisbroth. Academic Press, New York, 1979, p. 178.
6. Bhargava, H. N. & G. A. Matwyshyn: Brain serotonin turnover and morphine tolerance-dependence induced by multiple injections in the rat. Eur. J. Pharmacol. 1977, 44, 25-33.
7. Bhargava, H. N. & G. A. Matwyshyn: Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome. Psychopharmacology 1985, 87, 141-146.
8. Bhargava, H. N., G. A. Matwyshyn, B. L. Currie & R. J. Goebel: Structure activity relationship studies with hypothalamic peptide hormones II. Effect of thyrotropin releasing hormone analogs on morphine-induced responses in mice. Life Sci. 1982, 30, 711-718.
9. Bradford, M. M. A.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
10. Collu, R., J.-C. Jéquier, J. Letarte, G. Leboeuf & J. R. Ducharme: Effect of stress and hypothalamic deafferentation on the secretion of growth hormone in the rat. Neuroendocrinology 1973, 11, 183-190.
11. Demarest, K. T., K. E. Moore & G. D. Reigle: Acute restraint stress decreases dopamine synthesis and turnover in the median eminence: a model for the study of the inhibitory neuronal influences on tuberoinfundibular dopaminergic neurons. Neuroendocrinology 1985, 41, 437-444.
12. Deyo, S. N., R. M. Swift, R. J. Miller & V. S. Fang: Development of tolerance to the prolactin-releasing action of morphine and its modulation by hypothalamic dopamine. Endocrinology 1980, 106, 1469-1474.
13. 2 terminus. J. Clin. Invest. 1986, 78, 906-913.
14. Gabriel, S. M., J. W. Simpkins & W. J. Millard: Changes in anterior pituitary hormone secretion and hypothalamic catecholamine metabolism during morphine withdrawal in the female rat. Brain Res. 1985, 346, 15-21.
15. Hagihara, M., H. Mihara, A. Togari & T. Nagatsu: Dipeptidylaminopeptidase II in human cerebrospinal fluid: changes in patients with Parkinsons disease. Biochem. Metabol. Biol. 1987, 37, 360-365.
16. Holaday, J. W., L. F. Tseng, H. H. Loh & C. H. Li: Thyrotropin releasing hormone antagonizes beta endophrine hypothermia and catalepsy. Life Sci. 1978, 22, 1537-1544.
17. Jobin, M., L. Ferland, J. Gote & F. Labric: Effect of exposure to cold on the hypothalamic TRH activity and plasma levels of TSH and prolactin in the rat. Neuroendocrinology 1975, 18, 204-212.
18. Johnston, C. A., E. J. Spinedi & A. Negro-Vilar: Effect of acute ether stress on monoamine metabolism in median eminence and discrete hypothalamic nuclei of the rat brain and on anterior pituitary hormone secretion. Neuroendocrinology 1985, 41, 83-88.
19. Kato, T., T. Nagatsu, T. Kimura & S. Sakakibara: Fluorescence assay of X-prolyl dipeptidyl-aminopeptidase with a new fluorogenic substate. Biochem. Med. Metabol. Biol. 1979, 19 351-359.
20. Kato, T. M. Okada & T. Nagatsu: Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Mol. Cell. Biochem. 1980, 32, 117-121.
21. Kehoe, L., J. Janik & P. Callahan: Effects of immobilization stress on tuberoinfundibular dopaminergic (TIDA) neuronal activity and prolactin levels in lactating and non-lactating female rats. Life Sci. 1992, 50, 55-63.
22. 2 in bovine and porcine plasma. Drug Metabol. Disp. 1989, 17, 393-397.
23. Kuhn, C. M. & M. B. Bartolome: Effect of chronic methadone administration on neuroendocrine function in young adult rats. J. Pharmacol. Exp. Therap. 1985, 234, 204-210
24. Martin, R. A., D. L. Cleary, D. M. Guido, H. A. Zurcher-Neely & T. M. Kubiak: Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. Extended DPP-IV substrate specificity? Biochem. Biophys. Acta 1993, 1164, 252-260.
25. Minamitani, N., T. Minamitani, R. M. Lechan, J. Bollinger-Gruber & S. Reichlin: Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat. Endocrinology 1987, 120, 860-869.
26. Mioduszewski, R., E. Zimmermann & V. Critchlow: Effects of morphine dependence, withdrawal and tolerance on prolactin and growth hormone secretion in the rat. Life Sci. 1982, 30, 1343-1348.
27. Morley, J. E., T. Yamada, J. H. Walsh, C. B. Lamers, H. Wong, A. Shulkes, D. A. Damassa, J. Gordon, H. E. Carlson & J. M. Hershman: Morphine addiction and withdrawal alters brain peptide concentrations. Life Sci. 1980, 26, 2239-2244.
28. Muraki, T. & Y. Tokunaga: Effects of morphine on the serum prolactin levels of morphine tolerant and nontolerant male rats and on the in vitro release of pituitary prolactin. Jap. J. Pharmacol. 1978, 28, 803-810.
29. Männistö, P. T.: Central regulation of thyrotropin secretion in rats: methodological aspects, problems and some progress. Med. Biol. 1983, 61, 92-98.
30. Männistö, P. T., P. Tuomainen, M. Toivonen, M. Törnwall & S. Kaakkola: Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats. J. Neural. Transm. 1990, 2, 31-42.
31. Männistö, P. T., E. Peuranen, J. Harro & E. Vasar: Possible role of cholecystokinin-A receptors in the regulation of thyrotropin secretion in male rats. Neuropeptides 1992, 23, 251-258.
32. Männistö, P. T., S. A. Borisenko, P. Rauhala, P. Tuomainen & R. K. Tuominen: Variation in tolerance to the antinociceptive, hormonal and thermal effects of morphine after a 5-day pre-treatment of male rats with increasing doses of morphine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 349, 1-9.
33. Rauhala, P., P. T. Männistö & R. K. Tuominen: Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat. J. Pharmacol. Exp. Therap. 1988, 246, 649-654.
34. Rauhala, P., R. K. Tuominen, P. Tuomainen, M. Toivonen, S. A. Borisenko & P. T. Männistö: Development of tolerance to the hormonal effects of morphine without changes in the brain aminergic functions in the rat. Neuropharmacology 1992, 31, 765-770.
35. Rauhala, P., J. J. Idänpään-Heikkilä, R. K. Tuominen & P. T. Männistö: N-Nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol. 1994, 259, 57-64.
36. Schalch, D. S. & S. Reichlin: Stress and growth hormone release. In: Growth hormone, Ed.: Pecile & Muller. Excerpta Medica Foundation, Amsterdam, 1968, pp. 211-225.
37. Shih, S. H.: Prolactin secretion in acute stress is controlled by prolactin releasing factor. Life Sci. 1979, 25, 1829-1835.
38. Stolerman, I. P., C. A. Johnson, P. Bunker & M. E. Jarvik: Weight loss and shock-elicited aggression as indices of morphine abstinence in rats. Psychopharmacologia 1975, 45, 157-161.
39. Su, C.-M., L. R. Jensen, E. P. Heimer, A. M. Felix, Y.-C. E. Pan & T. F. Mowles: In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma. Horm. metab. Res. 1991, 23, 15-21.
40. Szabo, M. & L. A. Frohman: Suppression of cold-stimulated thyrotropin secretion by antiserum to thyrotropin-releasing hormone. Endocrinology 1977, 101, 1023-1033.
41. Tallarida, R. J. & R. B. Murray: Manual of pharmacological calculations with computer programs. Springer-Verlag, New York, 1987.
42. Tuomisto, J. & P. T. Männistö: Neutrotransmitter regulation of anterior pituitary hormones. Pharmacol. Rev. 1985, 37, 249-332.
43. van Wimersma Greidanus, T. B. & A. B. Grossman: Opioid regulation of pituitary function. Prog. Sens. Physiol. 1991, 12, 1-64.
44. Walter, R., W. H. Simmons & T. Yoshimoto: Proline specific endoand exopeptidases. Mol. Cell. Biochem. 1980, 30, 111-127.
45. Wuttke, W., G. Flugge, H. Jarry, R. Wolf, M. Sprenger & A. Meyer-Fleitmann: In vivo release rate of neurotransmitters in the control of pituitary prolactin release. In: Prolactin. Basic and clinical correlates. Ed.: R. M. MacLeod, M. O. Throner & U. Scapaginini. Liviana Press, Padova, 1985, p. 509.
46. Yoshimoto, T., K. Ogita, R. Walter, M. Koida & D. Tsuru: Postproline cleaving enzyme. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluid of man. Biochim. Biophys. Acta 1979, 569, 184-192.